Editor’s Note
**Editor’s Note:** Medytox launches its new MAP academic program with the inaugural CORE Live Seminar, aimed at deepening domestic medical professionals’ understanding of its HA filler Neuramis.
Medytox (CEO Jung Hyun-ho) has launched a new academic education program and is enhancing domestic medical professionals’ understanding of its HA (hyaluronic acid) filler ‘Neuramis’.
Medytox announced on the 21st that it successfully held the ‘MAP Institute CORE Live Seminar’, the first event of its ‘MAP (Medytox Academy of Precision)’ program.
According to the company, MAP is a new integrated academic education program that operates various academic events based on educational objectives and the capabilities of medical professionals.
Among these, the MAP Institute CORE Live Seminar is an educational program focused on deepening understanding of Medytox products and strengthening basic procedural competencies.
At the event, attended by approximately 30 domestic medical professionals, Dr. Hong Ki-woong, Director of Samskin Plastic Surgery Clinic, introduced the physicochemical characteristics of the HA filler ‘Neuramis’ series and conducted a live demonstration of mid-face and nasolabial fold procedures using ‘Neuramis Deep Lidocaine’ and ‘Volume Lidocaine’.
The company reported that Dr. Hong shared safe and effective treatment strategies and complication prevention know-how through the demonstration.
Medytox plans to fully operate MAP starting with this event, running academic education programs covering various products and procedure areas, including webinars, forums, and symposiums.